[Federal Register: December 16, 2003 (Volume 68, Number 241)]
[Notices]               
[Page 70018]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16de03-53]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Cooperative Agreement for Research on the 
Laboratory Diagnosis, Immunology and Pathogenesis of Lyme Disease in 
the United States, Program Announcement 04006

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Cooperative Agreement for Research on 
the Laboratory Diagnosis, Immunology, and Pathogenesis of Lyme 
Disease in the United States, Program Announcement 04006.
    Times and Dates: 8:30 a.m.-9 a.m., January 14, 2004 (Open); 9 
a.m.-6 p.m., January 14, 2004 (Closed).
    Place: Atlanta Airport Marriott, 4711 Best Road, Atlanta, GA 
30337, Telephone (404) 766-7900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 04006.
    For Further Information Contact: Nora L. Keenan, Ph.D., 
Scientific Review Administrator, Office of Extramural Research, 
National Center for Infectious Diseases, CDC, 1600 Clifton Road, NE, 
MS-C19, Atlanta, GA 30333, Telephone (404) 639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: December 3, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-30956 Filed 12-15-03; 8:45 am]

BILLING CODE 4163-18-P